Salvatore Petta

2007–2026 年に発表

193
論文数
25,059
被引用数
85
h 指数
182
i10 指数

被引用数

Salvatore Petta の年別被引用数2001 年: 被引用 1 件2004 年: 被引用 1 件2006 年: 被引用 1 件2008 年: 被引用 3 件2009 年: 被引用 10 件2010 年: 被引用 18 件2011 年: 被引用 37 件2012 年: 被引用 47 件2013 年: 被引用 74 件2014 年: 被引用 103 件2015 年: 被引用 143 件2016 年: 被引用 161 件2017 年: 被引用 210 件2018 年: 被引用 207 件2019 年: 被引用 806 件2020 年: 被引用 1,170 件2021 年: 被引用 1,491 件2022 年: 被引用 1,383 件2023 年: 被引用 1,199 件2024 年: 被引用 2,121 件2025 年: 被引用 1,134 件2026 年: 被引用 65 件2002〜2003 年は被引用が無いため表示していません2005 年は被引用が無いため表示していません2007 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,027 件、この内訳の 16.1%中国: 引用元論文 1,516 件、この内訳の 12%イタリア: 引用元論文 1,226 件、この内訳の 9.7%イギリス: 引用元論文 795 件、この内訳の 6.3%ドイツ: 引用元論文 604 件、この内訳の 4.8%スペイン: 引用元論文 456 件、この内訳の 3.6%日本: 引用元論文 427 件、この内訳の 3.4%フランス: 引用元論文 413 件、この内訳の 3.3%韓国: 引用元論文 322 件、この内訳の 2.6%オーストラリア: 引用元論文 282 件、この内訳の 2.2%スウェーデン: 引用元論文 266 件、この内訳の 2.1%カナダ: 引用元論文 260 件、この内訳の 2.1%
0%16.1%その他 31.8%

分野

  • Medicine89%
  • Biochemistry, Genetics and Molecular Biology6.5%
  • Immunology and Microbiology1.4%
  • Nursing0.5%
  • Environmental Science0.4%
  • Health Professions0.4%
  • その他1.8%

トピック

  • Liver Disease Diagnosis and Treatment26%
  • Liver Disease and Transplantation8.1%
  • Diet, Metabolism, and Disease5.8%
  • Hepatitis C virus research4.1%
  • Diabetes, Cardiovascular Risks, and Lipoproteins3.5%
  • Hepatocellular Carcinoma Treatment and Prognosis3.3%
  • その他49.2%

共著者

全論文

検索で開く
  1. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update

    著者: , , , , , , , - Journal of Hepatology 2021 被引用: 1,753

  2. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Homie Razavi - Journal of Hepatology 2018 被引用: 2,008

  3. Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis

    著者: , , , , , , , , , , , , , , , - The American Journal of Gastroenterology 2016 被引用: 891

  4. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Won Kim, Myoung Seok Lee, Johannes Wiegand, Thomas Karlas, Yusuf Yılmaz, Guruprasad P. Aithal, Naaventhan Palaniyappan, Christophe Cassinotto, Sandeep Aggarwal, Harshit Garg, Geraldine Ooi, Atsushi Nakajima, Masato Yoneda, Marianne Ziol, Nathalie Barget, Andreas Geier, Theresa Tuthill, M. Julia Brosnan, Quentin M. Anstee, Stefan Neubauer, Stephen A. Harrison, Patrick M. Bossuyt, Michael Pavlides - Gut 2021 被引用: 485

  5. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2020 被引用: 454

  6. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2020 被引用: 514

  7. Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kevin Kim‐Jun Teh, Carmen Lara‐Romero, Amon Asgharpour, Sara Mahgoub, Mandy Sau-Wai Chan, Clémence M. Canivet, Manuel Romero‐Gómez, Seung Up Kim, Vincent Wai‐Sun Wong, VCTE-Prognosis Study Group - JAMA 2024 被引用: 201

  8. Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guruprasad P. Aithal, Jörn M. Schattenberg, Elisabetta Bugianesi, Manuel Romero‐Gómez, Vlad Ratziu, Quentin M. Anstee, Patrick M. Bossuyt - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 196

  9. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Vlad Ratziu, Karine Clément, Raluca Pais, Detlef Schuppan, Jörn M. Schattenberg, Toni Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas, Evangelia Petsalaki, Matej Orešič, Tuulia Hyötyläinen, Aiden McGlinchey, José M. Mato, Óscar Millet, Jean‐François Dufour, Annalisa Berzigotti, Michael Pavlides, Stephen A. Harrison, Stefan Neubauer, Jeremy Cobbold, Ferenc E. Mózes, Salma Akhtar, Rajarshi Banerjee, Matt Kelly, Elizabeth Shumbayawonda, Andrea Dennis, Charlotte Erpicum, Manuel Romero‐Gómez, Emilio Gómez-González, Javier Ampuero, Javier Castell, Rocío Gallego‐Durán, Isabel Fernández-Lizaranzu, Rocío Montero‐Vallejo, M.A. Karsdal, Elisabeth Erhardtsen, Daniel Guldager Kring Rasmussen, Diana Julie Leeming, Mette Juul Fisker, Antonia Sinisi, Kishwar Musa, Fay Betsou, Estelle Sandt, Manuela Tonini, Elisabetta Bugianesi, Chiara Rosso, Angelo Armandi, Fabio Marra, Amalia Gastaldelli, Gianluca Svegliati, Jérôme Boursier, Sven Francque, Luisa Vonghia, Mattias Ekstedt, Stergios Kechagias, Hannele Yki‐Järvinen, Panu K. Luukkonen, Saskia W. C. van Mil, George Papatheodoridis, Helena Cortez‐Pinto, Luca Valenti, Salvatore Petta, Luca Miele, Andreas Geier ほか 35 名 - Journal of Hepatology 2021 被引用: 353

  10. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hannes Hagström, Camilla Akbari, Masashi Hirooka, Wah‐Kheong Chan, Sanjiv Mahadeva, Ruveena Bhavani Rajaram, Ming‐Hua Zheng, Jacob George, Mohammed Eslam, Salvatore Petta, Grazia Pennisi, Mauro Viganò, Sofia Ridolfo, Guruprasad P. Aithal, Naaventhan Palaniyappan, Dae Ho Lee, Mattias Ekstedt, Patrik Nasr, Christophe Cassinotto, Victor de Lédinghen, Annalisa Berzigotti, Yuly P. Mendoza, Mazen Noureddin, Emily Truong, Céline Fournier‐Poizat, Andreas Geier, Miljen Martić, Theresa Tuthill, Quentin M. Anstee, Stephen A. Harrison, Patrick M. Bossuyt, Michael Pavlides, Quentin M. Anstee, Ann K. Daly, Olivier Govaere, Simon Cockell, Dina Tiniakos, Pierre Bédossa, Alastair D. Burt, Fiona Oakley, Heather J. Cordell, Christopher P. Day, Kristy Wonders, Paolo Missier, Matthew McTeer, Luke Vale, Yemi Oluboyede, Matt Breckons, Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Max Nieuwdorp, Adriaan G. Holleboom, Joanne Verheij, Vlad Ratziu, Karine Clément, Rafael Patiño‐Navarrete, Raluca Pais, Valérie Paradis, Detlef Schuppan, Jörn M. Schattenberg, Rambabu Surabattula, Sudha Rani Myneni, Beate K. Straub, Toni Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas ほか 130 名 - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 187

  11. Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2020 被引用: 362

  12. MAFLD: a multisystem disease

    著者: , , , , , , , , - Therapeutic Advances in Endocrinology and Metabolism 2023 被引用: 216

  13. The first MASH drug therapy on the horizon: Current perspectives of resmetirom

    著者: , , , , , , - Liver International 2024 被引用: 151

  14. Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marco Maggioni, Roberta D’Ambrosio, Valentina Vaira, Anna Ludovica Fracanzani, Chiara Rosso, Grazia Pennisi, Salvatore Petta, Antonio Liguori, Luca Miele, Federica Tavaglione, Umberto Vespasiani‐Gentilucci, Marcello Dallio, Alessandro Federico, Giorgio Soardo, Jussi Pihlajamäki, Ville Männistö, Sara Della Torre, Daniele Prati, Stefano Romeo, Luca Valenti - Nature Medicine 2023 被引用: 131

  15. The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2016 被引用: 664

  16. Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Internal Medicine 2017 被引用: 368

  17. Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease

    著者: , , , , , , , , , , , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2020 被引用: 185

  18. Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Baki Topal, Karine Clément, Stefano Romeo, Vlad Ratziu, Tania Roskams, Ann K. Daly, Quentin M. Anstee, Matthias Trost, Anetta Härtlová - Journal of Hepatology 2021 被引用: 160

  19. Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation

    著者: , , , , , , , , , , , , , , , , , - Hepatology 2019 被引用: 322

  20. Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Hepatology 2014 被引用: 529

  21. Geographical similarity and differences in the burden and genetic predisposition of NAFLD

    著者: , , , , , , , , - Hepatology 2022 被引用: 120

  22. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation

    著者: , , , - Transplantation 2018 被引用: 400

  23. Accuracy, Reliability, and Comprehensibility of ChatGPT-Generated Medical Responses for Patients With Nonalcoholic Fatty Liver Disease

    著者: , , , , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2023 被引用: 84

  24. Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2021 被引用: 191